EUVIMEDEUVIMED entdecken
Crossref

Expanding the Cutaneous Presentation of Blau Syndrome, Response to Treatment, and Correlation With Genetics

Nessa Aghazadeh Mohandesi, Setu Mittal iD, Amir B Orandi iD, Wendy M Smith, Nila S Khan, Dawn Marie Davis iD

Pediatric Dermatology · 2025

DOI: 10.1111/pde.15994 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pediatric Dermatology, 2025. Verfasst von Nessa Aghazadeh Mohandesi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Mayo Clinic, Rochester, Minnesota, USA. Hauptthemen laut MEDLINE: Arthritis, Nod2 Signaling Adaptor Protein, Synovitis, Uveitis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 16 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Blau syndrome is a rare, autosomal dominant granulomatous disease caused by mutations in the NOD2/CARD15 gene. While the classic triad of arthritis, dermatitis, and uveitis is well known, the full range of cutaneous manifestations remains underexplored.

Objective

To expand the understanding of cutaneous findings in Blau syndrome, correlate these findings with NOD2 variants, and evaluate treatment outcomes across organ systems.

Methods

A retrospective review of medical records from January 1999 to January 2024 identified 14 patients with Blau syndrome supported by the presence of NOD2 variants. Clinical data on dermatological features, genetics, and treatment responses were analyzed and categorized into specific and non‐specific cutaneous findings.

Results

Of the 14 patients with Blau syndrome, 85% (12/14) demonstrated skin involvement. Specific findings included lichenoid or granulomatous papules and nodules (50%, 6/12), while non‐specific findings (83%, 10/12) were more diverse, including dermatitis (6/10), chronic urticaria (5/10), ichthyosiform eruptions (4/10), vasospastic disorders (5/10), and oral/genital ulcers (2/10). Skin biopsies in three patients with specific findings revealed non‐caseating granulomas. Genetic analysis identified multiple NOD2 variants, though no clear genotype–phenotype correlation was observed. TNF‐alpha inhibitors demonstrated efficacy in controlling ocular and joint disease.

Conclusion

Blau syndrome presents with a broader spectrum of cutaneous findings than previously recognized. These findings highlight the importance of dermatological evaluation and a multidisciplinary approach to optimize diagnosis and management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ArthritisNod2 Signaling Adaptor ProteinSynovitisUveitisHumansRetrospective StudiesFemaleMaleChildChild, PreschoolMutationAdolescentInfantSarcoidosisGenetic Association StudiesHereditary Autoinflammatory Diseases

Stichwörter der Autor:innen

NOD2 mutationBlau syndromeTNF‐alpha inhibitorscutaneous manifestationstreatment

Substanzen

Nod2 Signaling Adaptor ProteinNOD2 protein, human

Autor:innen und Institutionen

  • Department of Dermatology, Mayo Clinic, Rochester, Minnesota, USA.
  • Department of Pediatric and Adolescent Medicine, Mayo Clinic Children's, Rochester, Minnesota, USA.
  • Department of Clinical Genomics, Mayo Clinic, Rochester, Minnesota, USA.
  • Department of Ophthalmology, Mayo Clinic, Rochester, Minnesota, USA.

ORCID-Profile: Setu Mittal, Amir B Orandi, Dawn Marie Davis

Zitieren

APA

Mohandesi, N. A., Mittal, S., Orandi, A. B., Smith, W. M., Khan, N. S., & Davis, D. M. (2025). Expanding the Cutaneous Presentation of Blau Syndrome, Response to Treatment, and Correlation With Genetics. Pediatric Dermatology. https://doi.org/10.1111/pde.15994

Vancouver

Mohandesi NA, Mittal S, Orandi AB, Smith WM, Khan NS, Davis DM. Expanding the Cutaneous Presentation of Blau Syndrome, Response to Treatment, and Correlation With Genetics. Pediatric Dermatology. 2025. doi:10.1111/pde.15994

BibTeX
@article{Mohandesi2025,
  author = {Mohandesi, Nessa Aghazadeh and Mittal, Setu and Orandi, Amir B and Smith, Wendy M and Khan, Nila S and Davis, Dawn Marie},
  title = {Expanding the Cutaneous Presentation of Blau Syndrome, Response to Treatment, and Correlation With Genetics},
  journal = {Pediatric Dermatology},
  year = {2025},
  doi = {10.1111/pde.15994}
}
Kostenlos starten →